Skip to content
stoqly

Clorox Co /De/

CLX NYSE Specialty Cleaning, Polishing And Sanitation Preparations Financials FY2016–FY2025

Revenue Total sales reported in the income statement.
$7.1B
0.2% vs prior year
Operating margin Operating income as a share of revenue.
—
Net income Profit after all expenses, interest and tax.
$810M
189.3%
Free cash flow Cash from operations minus capital spending.
$761M
57.6%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
—
Market cap Last close times the latest diluted share count, so it is approximate.
—
P/E Last close divided by diluted earnings per share over the last four quarters.
—
On $6.16 EPS (TTM)

What Clorox Co /De/ does

No business description yet.

Legal name
CLOROX CO /DE/
Fiscal year ends
June 30, 2025
Latest annual report
10-K · Aug 7, 2026
Accession · CIK
0000021076-26-000034
0000021076

Revenue and margins

Clorox Co /De/ had $7.1B of revenue in fiscal 2025, up 0.2% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 3.2% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $761M in fiscal 2025, 10.7% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Clorox Co /De/ returned $934M to shareholders in fiscal 2025, 123% of free cash flow. The diluted share count fell 0.4%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Clorox Co /De/ can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $319M$183M$367M$202M$167M
Debt incl. finance leases $2.8B$2.7B$2.6B$2.5B$2.5B
Debt / equity 6.8x4.9x11.5x7.6x7.8x
Current ratio 0.9x1.0x1.0x1.0x0.8x
Quick ratio 0.5x0.5x0.6x0.6x0.6x
Total assets $6.3B$6.2B$5.9B$5.8B$5.6B
Total liabilities $5.7B$5.4B$5.6B$5.3B$5.1B
Shareholders' equity $411M$556M$220M$328M$321M
Net debt (− = net cash) $2.5B$2.5B$2.2B$2.3B$2.4B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

—

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Net income is positive ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Return on assets rose — ✓ ✓ ✕ ✕ ✕ ✕ ✕ ✓ ✓
Cash from operations exceeds net income ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Debt fell relative to assets — ✓ ✕ ✕ ✓ ✓ ✕ ✓ ✕ ✕
Current ratio rose — ✕ ✓ ✕ ✓ ✕ ✓ ✕ ✓ ✕
Share count didn't rise — ✓ ✕ ✓ ✓ ✓ ✓ ✕ ✕ ✓
Gross margin rose — ✕ ✕ ✓ ✓ ✕ ✕ ✓ ✓ ✓
Revenue rose relative to assets — ✓ ✕ ✓ ✕ ✓ ✕ ✓ ✕ ✓
F-score — / 37 / 95 / 96 / 97 / 96 / 95 / 96 / 96 / 97 / 9
Accruals ratio −2.9%−3.6%−3.2%−3.4%−10.7%−9.0%−5.2%−16.7%−7.1%−3.0%
Altman Z'' ——————————

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $5.8B $6.0B $6.1B $6.2B $6.7B $7.3B $7.1B $7.4B $7.1B $7.1B
Gross profit $2.6B $2.7B $2.7B $2.7B $3.1B $3.2B $2.5B $2.9B $3.0B $3.2B
Research and development $141M $135M $132M $136M $145M $149M $132M $138M $126M $121M
Interest expense $88.0M $88.0M $85.0M $97.0M $99.0M $99.0M $106M $90.0M $90.0M $88.0M
Pretax income $983M $1.0B $1.1B $1.0B $1.2B $900M $607M $238M $398M $1.1B
Income tax $335M $330M $231M $204M $246M $181M $136M $77.0M $106M $254M
Net income $648M $701M $823M $820M $939M $710M $462M $149M $280M $810M
Diluted EPS $4.92 $5.33 $6.26 $6.32 $7.36 $5.58 $3.73 $1.20 $2.25 $6.52
Diluted shares 0.13B 0.13B 0.13B 0.13B 0.13B 0.13B 0.12B 0.12B 0.12B 0.12B
Cash flow
Cash from operations $778M $865M $976M $992M $1.5B $1.3B $786M $1.2B $695M $981M
Capital expenditure $172M $231M $194M $206M $254M $331M $251M $228M $212M $220M
Free cash flow $606M $634M $782M $786M $1.3B $945M $535M $930M $483M $761M
Depreciation and amortization $165M $163M $166M $180M $180M $211M $224M $236M $235M $219M
Stock-based compensation $45.0M $51.0M $53.0M $43.0M $50.0M $50.0M $52.0M $73.0M $74.0M $81.0M
Acquisitions $290M $0.0M $681M $0.0M $0.0M $85.0M $0.0M $0.0M — —
Share buybacks $254M $183M $271M $661M $248M $905M $25.0M $0.0M $0.0M $332M
Dividends paid $398M $412M $450M $490M $533M $558M $571M $583M $595M $602M
Dividends and buybacks $652M $595M $721M $1.2B $781M $1.5B $596M $583M $595M $934M
Balance sheet
Cash and short-term investments $401M $418M $131M $111M $871M $319M $183M $367M $202M $167M
Total debt $2.3B $2.2B $2.5B $2.7B $2.8B $2.8B $2.7B $2.5B $2.5B $2.5B
Finance lease liabilities — — — — $14.0M $20.0M $19.0M $30.0M $34.0M $36.0M
Current assets $1.5B $1.5B $1.3B $1.3B $2.0B $1.8B $1.7B $1.8B $1.6B $1.6B
Current liabilities $1.6B $1.8B $1.2B $1.4B $1.4B $2.1B $1.8B $1.9B $1.6B $1.9B
Inventory $443M $459M $506M $512M $454M $752M $755M $696M $637M $523M
Property and equipment, net $906M $931M $996M $1.0B $1.1B $1.3B $1.3B $1.3B $1.3B $1.3B
Goodwill $1.2B $1.2B $1.6B $1.6B $1.6B $1.6B $1.6B $1.3B $1.2B $1.2B
Intangible assets $735M $722M $929M $912M $894M $918M $884M $712M $681M $566M
Total assets $4.5B $4.6B $5.1B $5.1B $6.2B $6.3B $6.2B $5.9B $5.8B $5.6B
Total liabilities $4.2B $4.0B $4.3B $4.6B $5.3B $5.7B $5.4B $5.6B $5.3B $5.1B
Preferred stock $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Shareholders' equity $297M $542M $726M $559M $908M $411M $556M $220M $328M $321M
Margins
Gross margin 45.1% 44.7% 43.7% 43.9% 45.6% 43.6% 35.8% 39.4% 43.0% 45.2%
Net margin 11.2% 11.7% 13.4% 13.2% 14.0% 9.7% 6.5% 2.0% 3.9% 11.4%
FCF margin 10.5% 10.6% 12.8% 12.6% 19.2% 12.9% 7.5% 12.6% 6.8% 10.7%
Returns
Return on equity 218.2% 167.1% 129.8% 127.6% 128.0% 107.7% 95.6% 38.4% 102.2% 249.6%
Return on assets 14.4% 15.4% 17.1% 16.1% 16.6% 11.3% 7.4% 2.5% 4.8% 14.3%
Growth
Revenue growth — 3.7% 2.5% 1.5% 8.2% 9.2% −3.2% 4.0% −4.0% 0.2%
Net income growth — 8.2% 17.4% −0.4% 14.5% −24.4% −34.9% −67.7% 87.9% 189.3%
EPS growth — 8.3% 17.4% 1.0% 16.5% −24.2% −33.2% −67.8% 87.5% 189.8%
FCF growth — 4.6% 23.3% 0.5% 64.4% −26.9% −43.4% 73.8% −48.1% 57.6%
Share count change — −0.1% 0.0% −1.4% −1.6% −0.3% −2.7% 0.2% 0.5% −0.4%
Financial health
Debt / equity 7.8x 4.0x 3.4x 4.8x 3.1x 6.8x 4.9x 11.5x 7.6x 7.8x
Current ratio 1.0x 0.8x 1.1x 0.9x 1.4x 0.9x 1.0x 1.0x 1.0x 0.8x
Quick ratio 0.7x 0.6x 0.7x 0.6x 1.1x 0.5x 0.5x 0.6x 0.6x 0.6x
Capital allocation
Capex / revenue 3.0% 3.9% 3.2% 3.3% 3.8% 4.5% 3.5% 3.1% 3.0% 3.1%
Stock comp / revenue 0.8% 0.9% 0.9% 0.7% 0.7% 0.7% 0.7% 1.0% 1.0% 1.1%
Payouts / FCF 107.6% 93.8% 92.2% 146.4% 60.4% 154.8% 111.4% 62.7% 123.2% 122.7%
Quality scores
Piotroski F-score — 7.0 5.0 6.0 7.0 6.0 5.0 6.0 6.0 7.0
Accruals ratio −2.9% −3.6% −3.2% −3.4% −10.7% −9.0% −5.2% −16.7% −7.1% −3.0%

Source: SEC EDGAR XBRL filings (CIK 0000021076). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open